Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation Vs Treatment Withdrawal With Retreatment Upon Relapse in Resurface 1. J of Skin 2020, 4 (5), s40. https://doi.org/10.25251/skin.4.supp.40.